Description

TRANCYP TABLET is a prescription medication containing Tranylcypromine, a non-hydrazine monoamine oxidase inhibitor (MAOI), indicated for the management of major depressive episodes, particularly in cases where patients have shown inadequate response to other antidepressants like SSRIs or tricyclics.

TRANCYP acts by irreversibly inhibiting the monoamine oxidase enzyme, thereby increasing the levels of key neurotransmitters such as serotonin, dopamine, and norepinephrine in the brain. These elevated neurotransmitter levels help alleviate the symptoms of severe or resistant depression.

This medication is often reserved for treatment-resistant cases due to the necessity for dietary restrictions and potential for drug interactions, and it is prescribed under close medical supervision.

Antidepressant – Monoamine Oxidase Inhibitor (MAOI)

Tranylcypromine irreversibly binds to and inhibits monoamine oxidase (types A and B), preventing the breakdown of neurotransmitters. This results in an increase in synaptic availability of mood-regulating chemicals, leading to improved emotional and cognitive function in depressive states.

• Major Depressive Disorder (MDD)

• Treatment-resistant depression

• Atypical depression

• Severe dysthymia (off-label, physician-directed use)

• Effective in managing resistant depression

• Useful where standard antidepressants have failed

• Can improve both mood and motivation

• May benefit anxiety symptoms in some patients

• Long-lasting effect due to irreversible enzyme inhibition

• Initial adult dose: 10 mg twice daily

• May be increased to 30–60 mg/day in divided doses, based on response and tolerability

• Effects may take 2–3 weeks to become fully apparent

• Must be discontinued gradually to avoid withdrawal symptoms

• Strict dietary restrictions must be followed to avoid hypertensive crisis (avoid tyramine-rich foods)

• Avoid combination with SSRIs, SNRIs, TCAs, and sympathomimetic agents

• Contraindicated in patients with cardiovascular disease, cerebrovascular disorders, or pheochromocytoma

• Not to be used within 14 days of other antidepressants

• Dizziness or lightheadedness

• Insomnia or restlessness

• Dry mouth

• Weight changes

• Orthostatic hypotension

• Rare but serious: hypertensive crisis, serotonin syndrome

BLUEPILL EXPRESS offers TRANCYP TABLET with full quality assurance and global regulatory support. Our facilities operate under WHO-GMP and ISO certifications, ensuring every unit is manufactured to exacting pharmaceutical standards.

We provide:

• Bulk supply for hospitals and government tenders

• Custom packaging and private labeling for distributors

• Documentation support: COA, MSDS, Stability Data

• Cold chain or compliance-specific logistics upon request

• Worldwide export coverage with rapid dispatch options

BLUEPILL EXPRESS is a global pharmaceutical exporter specializing in high-quality generic and branded medications. We serve clients in:

• Latin America

• Africa & MENA

• Southeast Asia

• CIS Countries

• Eastern Europe

As a full-service pharma export company, we support our partners with product registration, regulatory dossiers, and consistent supply reliability.